Advertisement

COPD

Chapter

Abstract

Chronic obstructive pulmonary disease (COPD ) is the fourth leading cause of death worldwide. In 2004, COPD was responsible for 3.02 million deaths or 5.1% of all deaths globally (World Health Organization 2008). COPD may account for more than 10% of lost disability-adjusted life years on a worldwide basis (Speizer et al. 2006). The global prevalence of COPD is significant: at any given time, 63.6 million individuals worldwide suffer from COPD. Of these COPD sufferers, 26.6 million experience moderate to severe disability as a result of the disease. This makes COPD the tenth most frequent cause of disability in the world (World Health Organization 2008). COPD is mainly a disease of older adults: more than 95% of all COPD-related deaths occur in people older than age 55 (Beers et al. 2006). Much of COPD can be attributed to cigarette smoking, and there is no question that smoking cessation can prevent further decline in pulmonary function. Yet air pollution is also an important trigger for COPD, particularly in developing countries. Both smoking-related COPD and pollution-related COPD are irreversible, and pulmonary function that is already lost cannot be regained. The disease is progressive; patients experience shortness of breath and exercise limitations which gradually and inevitably worsen over time, stressing the cardiopulmonary system. Patients with COPD typically die of respiratory failure, cardiovascular complications, or co-existing cancer. Importantly, COPD is an independent risk factor for cardiovascular disease (Maclay et al. 2007). In fact, COPD often develops together with one or more comorbid conditions and almost never occurs alone (Luppi et al. 2008). Currently available treatments for COPD are primarily symptomatic therapies, including pulmonary rehabilitation; bronchodilators to improve airflow; corticosteroids to reduce inflammation; and supplemental oxygen. These interventions cannot stop the eventual worsening of COPD. However, emerging biomaterials for lung regeneration can potentially replace lung tissue that has been destroyed by COPD, ultimately reducing morbidity and mortality from this relentless disease.

Keywords

Lung Tissue Chronic Bronchitis Pulmonary Rehabilitation Alveolar Wall Clara Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Andrade CF, Wong AP, Waddell TK et al (2007) Cell-based tissue engineering for lung regeneration. Am J Physiol Lung Cell Mol Physiol 292:L510CrossRefGoogle Scholar
  2. Badham C (1814) An essay on bronchitis: with a supplement containing remarks on simple pulmonary abscess, 2nd edn. J Callow, LondonGoogle Scholar
  3. Barnes PJ (2007) Chronic obstructive pulmonary disease: a growing but neglected global epidemic. PLoS Med 4:e112CrossRefGoogle Scholar
  4. Barnes PJ, Kleinert S (2004) COPD– a neglected disease. Lancet 364:564CrossRefGoogle Scholar
  5. Beers MH, Porter RS, Jones TV et al (2006) Merck manual of diagnosis and therapy, 18th edn. Wiley, New York, NYGoogle Scholar
  6. Blau H, Guzowski DE, Siddiqi ZA et al (1988) Fetal type 2 pneumocytes form alveolar-like structures and maintain long-term differentiation on extracellular matrix. J Cell Physiol 136:203CrossRefGoogle Scholar
  7. Bonet T (1679) Sepulchretum sive anatonia pructica ex Cadaveribus Morbo denatis, proponens Histoa’s Observations omnium pené humani corporis affectuum, ipsarcomoue Causas recorditas revelans, GenevaGoogle Scholar
  8. Burrows B, Knudson RJ, Camilli AE et al (1987) The “horse-racing effect” and predicting decline in the forced expiratory volume in one second from screening spirometry. Am Rev Respir Dis 135:788Google Scholar
  9. Calverly PM, Koulouris NG (2005) Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology. Eur Respir J 25:186CrossRefGoogle Scholar
  10. Chakir J, Pagé N, Hamid Q et al (2001) Bronchial mucosa produced by tissue engineering: a new tool to study cellular interactions in asthma. J Allergy Clin Immunol 107:36CrossRefGoogle Scholar
  11. Christie RV (1944) Emphysema of the lungs (part II). BMJ 1–145Google Scholar
  12. Cook NR, Hebert PR, Satterfield S et al (1994) Height, lung function, and mortality from cardiovascular disease among the elderly. Am J Epidemiol 139:1066Google Scholar
  13. Coraux C, Nawrocki-Raby B, Hinnrasky J et al (2005) Embryonic stem cells generate airway epithelial tissue. Am J Respir Cell Mol Biol 32:87CrossRefGoogle Scholar
  14. Cortiella J, Nichols JE, Kojima K et al (2006) Tissue-engineered lung: an in vivo and in vitro comparison of polyglycolic acid and pluronic F-127 hydrogel/somatic lung progenitor cell constructs to support tissue growth. Tissue Eng 12:1213CrossRefGoogle Scholar
  15. Croxton TL, Bailey WC (2006) Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: an NHLBI workshop report. Am J Respir Crit Care Med 174:373CrossRefGoogle Scholar
  16. Devereux G (2006) ABC of chronic obstructive pulmonary disease. Definition, epidemiology, and risk factors. BMJ 332:1142CrossRefGoogle Scholar
  17. Freitas RA Jr (1999) Nanomedicine, volume I: basic capabilities. Landes Bioscience, Georgetown, TXGoogle Scholar
  18. Giangreco A, Reynolds SD, Stripp BR (2002) Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. Am J Pathol 161:173CrossRefGoogle Scholar
  19. Halbert RJ, Natoli JL, Gano A et al (2006) Global burden of COPD: systematic review and meta-analysis. Eur Respir J 28:523CrossRefGoogle Scholar
  20. Hermanns MI, Unger RE, Kehe K et al (2004) Lung epithelial cell lines in coculture with human pulmonary microvascular endothelial cells: development of an alveolo-capillary barrier in vitro. Lab Invest 84:736CrossRefGoogle Scholar
  21. Kim CF, Jackson EL, Woolfenden AE et al (2005) Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121:823CrossRefGoogle Scholar
  22. Kotov NA, Liu Y, Wang S et al (2004) Inverted colloidal crystals as three-dimensional cell scaffolds. Langmuir 20:7887CrossRefGoogle Scholar
  23. Krause DS, Theise ND, Collector MI et al (2001) Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105:369CrossRefGoogle Scholar
  24. Laënnec RTH (1821) In: Forbes J (ed) A treatise on the diseases of the chest (English translation from the French). T and G Underwood; LondonGoogle Scholar
  25. Løkke A, Lange P, Scharling H et al (2006) Developing COPD: a 25 year follow up study of the general population. Thorax 61:935CrossRefGoogle Scholar
  26. Lopez AD, Shibuya K, Rao C et al (2006) Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 27:397CrossRefGoogle Scholar
  27. Luppi F, Franco F, Beghé B et al (2008) Treatment of chronic obstructive pulmonary disease and its comorbidities. Proc Am Thorac Soc 5:848CrossRefGoogle Scholar
  28. Maclay JD, McAllister DA, Macnee W (2007) Cardiovascular risk in chronic obstructive pulmonary disease. Respirology 12:834CrossRefGoogle Scholar
  29. Mills NL, Miller JJ, Anand A et al (2008) Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk. Thorax 63:306CrossRefGoogle Scholar
  30. Mondrinos MJ, Koutzaki S, Jiwanmall E et al (2006) Engineering three-dimensional pulmonary tissue constructs. Tissue Eng 12:717CrossRefGoogle Scholar
  31. Mondrinos MJ, Koutzaki S, Lelkes PI et al (2007) A tissue-engineered model of fetal distal lung tissue. Am J Physiol Lung Cell Mol Physiol 293:L639CrossRefGoogle Scholar
  32. Mondrinos MJ, Koutzaki SH, Poblete HM et al (2008) In vivo pulmonary tissue engineering: contribution of donor-derived endothelial cells to construct vascularization. Tissue Eng A 14:361CrossRefGoogle Scholar
  33. Morgagni GB (1769) The seats and causes of disease. In: Investigated by anatomy; in five books, containing a great variety of dissections, with remarks (trans: Alexander B, Miller A, Caldwell T). Johnson and Payne, LondonGoogle Scholar
  34. Nichols JE, Cortiella J (2008) Engineering of a complex organ: progress toward development of a tissue-engineered lung. Proc Am Thorac Soc 5:723CrossRefGoogle Scholar
  35. O’Donnell DE (2006) Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 3:180CrossRefGoogle Scholar
  36. Public Library of Science (2004) T cells cause lung damage in emphysema. PLoS Med 1:e25Google Scholar
  37. Rabe KF, Hurd S, Anzueto A et al (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176:532CrossRefGoogle Scholar
  38. Rippon HJ, Polak JM, Qin M et al (2006) Derivation of distal lung epithelial progenitors from murine embryonic stem cells using a novel three-step differentiation protocol. Stem Cells 24:1389CrossRefGoogle Scholar
  39. Schunemann HJ, Dorn J, Grant BJ et al (2000) Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo health study. Chest 118:656CrossRefGoogle Scholar
  40. Shanbhag S, Wang S, Kotov NA (2005) Cell distribution profiles in three-dimensional scaffolds with inverted-colloidal-crystal geometry: modeling and experimental investigations. Small 1:1208CrossRefGoogle Scholar
  41. Shannon JM, Mason RJ, Jennings SD et al (1987) Functional differentiation of alveolar type II epithelial cells in vitro: effects of cell shape, cell-matrix interactions and cell-cell interactions. Biochim Biophys Acta 931:143CrossRefGoogle Scholar
  42. Shigemura N, Okumura M, Mizuno S et al (2006) Lung tissue engineering technique with adipose stromal cells improves surgical outcome for pulmonary emphysema. Am J Respir Crit Care Med 174:1199CrossRefGoogle Scholar
  43. Smith KR (2000) Inaugural article: national burden of disease in India from indoor air pollution. Proc Natl Acad Sci USA 97:13286CrossRefGoogle Scholar
  44. Speizer FE, Horton S, Batt J et al (2006) Respiratory diseases of adults. In: Jamison DT, Breman JG, Measham AR et al (eds) Disease control priorities in developing countries, 2nd edn. IBRD/The World Bank and Oxford University Press, Washington, DCGoogle Scholar
  45. Sugihara H, Toda S, Miyabara S et al (1993) Reconstruction of alveolus-like structure from alveolar type II epithelial cells in three-dimensional collagen gel matrix culture. Am J Pathol 142:783Google Scholar
  46. World Health Organization (2008) The global burden of disease: 2004 update. WHO Press, GenevaGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Central Research and Development, DuPont CompanyWilmingtonUSA

Personalised recommendations